Which indicates that the short term of inbitor generation is 3.3%(1/30).Conclusion Kogenate FS has better efficacy, safety and lower inhibitor generation in Chinese patients with hemophilia A.

• 然而，拜科奇在中国血友病A人群中临床使用的有效性和安全性需要更多的重复研究。